View Older Stories View More Recent Stories

Mar 3, 2025 08:00AM HeyMilo Secures $2.2 Million to Interview and Evaluate Candidates at Scale with AI Agents
Feb 18, 2025 11:15AM Valid Raises $5.5 Million to Build the AI-Enabled Ad Agency of the Future
Feb 10, 2025 05:00PM Rondo Therapeutics Presents Preclinical Data at ASCO GU for its Novel CD28 x Nectin-4 Costimulatory Bispecific Antibody for Advanced Bladder Cancer
Jan 28, 2025 09:00AM WiseLayer Secures $7.2 Million to Power AI Workers for Finance & Accounting Teams
Jan 21, 2025 04:31PM Form 13F-HR Canaan Partners XI LLC For: Dec 31
Jan 21, 2025 04:30PM Form N-PX Canaan Partners IX LLC For: Sep 30
Jan 13, 2025 06:00AM Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms
Jan 9, 2025 10:15AM CatalYm Appoints Scott Clarke CEO as Company Initiates Global Phase 2b Clinical Development Program for Visugromab
Jan 8, 2025 08:00AM Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
Jan 7, 2025 05:01PM Form 144 Arbe Robotics Ltd. Filed by: Canaan Partners Israel (CPI) Cayman (L.P.)
Dec 4, 2024 08:00AM Rondo Therapeutics Announces Collaboration with Lilly to Develop Novel CD28 Bispecific Antibodies for Solid Tumors
Dec 4, 2024 07:00AM Enterpret Announces $20.8 Million Series A
Nov 21, 2024 09:00AM Nivoda Sparkles: Secures $51M to Expand Global Diamond Supply Chain
Nov 18, 2024 08:00AM Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
Oct 23, 2024 07:00AM Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Oct 16, 2024 04:31PM Form 13F-HR Canaan Partners IX LLC For: Sep 30
Oct 16, 2024 04:31PM Form 13F-HR Canaan Partners XI LLC For: Sep 30
Oct 1, 2024 08:30AM Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer
Sep 19, 2024 11:00AM Safire Group Raises $8 Million in New Financing to Deliver Lithium-ion Battery Safety Technology to Government, Automotive Markets
Sep 10, 2024 09:00AM AttoTude Raises $29M in Series A to Revolutionize High Speed Networking for AI and Hyperscale Data Center Applications
Aug 28, 2024 08:30AM Two Meter Capital Launches to Provide Expert Fund Management Services to Optimize Returns
Aug 15, 2024 09:00AM Quantum Circuits Secures More Than $60 Million in Series B Investment
Aug 13, 2024 04:31PM Form N-PX Canaan Partners XI LLC For: Jun 30
Aug 13, 2024 04:29PM Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Aug 12, 2024 07:00AM Halda Therapeutics Secures $126 Million Financing to Advance RIPTAC™ Cancer Therapies into the Clinic for Major Solid Tumors
Aug 7, 2024 01:59PM Tari Gains Native Bitcoin Access & Cross-Chain Accessibility with Portal to Bitcoin Integration
Aug 7, 2024 01:59PM Tari Gains Native Bitcoin Access & Cross-Chain Accessibility with Portal to Bitcoin Integration
Aug 6, 2024 09:00AM Kepler Communications Appoints Dan Budlovsky As New Chief Financial Officer
Jul 24, 2024 07:00AM Autobahn Therapeutics Completes Oversubscribed $100 Million Series C Financing to Advance Pipeline of Novel Therapeutics for Depression and Other CNS Disorders
Jul 16, 2024 05:10AM Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
Jul 16, 2024 05:10AM Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
Jul 16, 2024 05:00AM CatalYm Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab
Jul 15, 2024 08:00AM Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London Intern
Jul 10, 2024 08:30AM Nagish Raises $16 Million to Revolutionize Communication for Individuals with Hearing Loss Through AI
Jul 9, 2024 04:31PM Form 13F-HR Canaan Partners XI LLC For: Jun 30
Jul 9, 2024 04:31PM Form 13F-HR Canaan Partners IX LLC For: Jun 30
Jul 8, 2024 09:00AM Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
Jul 2, 2024 07:00AM ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program with Initial Focus on Inflammatory Gastrointestinal Disease Ulcerative Colitis
Jun 17, 2024 08:00AM Only Four Months Out of Stealth, Aim Security Closes $18M Series A to Secure Generative AI Enterprise Adoption
Jun 11, 2024 06:00AM Kepler Validates SDA-Compatible Optical Technology For Space Data Relay Constellation
Jun 4, 2024 11:16AM Lev expands suite of CRE services with launch of AI-powered pipeline management tool
May 15, 2024 04:20PM Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 14, 2024 09:00AM Truveris Secures $15 Million in Series E Funding Through Canaan Partners and New Leaf Venture Partners
Apr 24, 2024 04:05PM Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Apr 18, 2024 07:00AM Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Apr 5, 2024 04:30PM Form 13F-HR Canaan Partners XI LLC For: Mar 31
Apr 5, 2024 04:30PM Form 13F-HR Canaan Partners IX LLC For: Mar 31
Apr 3, 2024 07:51AM Cancer biotech firm Alterome Therapeutics raises $132 million in Goldman Sachs-led round
Apr 3, 2024 06:00AM Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Mar 26, 2024 02:50PM Software Supply Chain Security Leader Binarly Closes $10.5 Million Financing Led by Two Bear Capital
View More Recent Stories View Older Stories